Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
Cho Y, Rangan G, Logeman C, Ryu H, Sautenet B, Perrone RD, Nadeau-Fredette AC, Mustafa RA, Htay H, Chonchol M, Harris T, Gutman T, Craig JC, Ong ACM, Chapman A, Ahn C, Coolican H, Kao JT, Gansevoort RT, Torres V, Pei Y, Johnson DW, Viecelli AK, Teixeira-Pinto A, Howell M, Ju A, Manera KE, Tong A. Cho Y, et al. Among authors: kao jt. Am J Kidney Dis. 2020 Sep;76(3):361-373. doi: 10.1053/j.ajkd.2020.01.005. Epub 2020 Apr 28. Am J Kidney Dis. 2020. PMID: 32359822
The screening, diagnosis, and management of patients with autosomal dominant polycystic kidney disease: A national consensus statement from Taiwan.
Yen PW, Chen YA, Wang W, Mao FS, Chao CT, Chiang CK, Lin SH, Tarng DC, Chiu YW, Wu MJ, Chen YC, Kao JT, Wu MS, Lin CL, Huang JW, Hung KY. Yen PW, et al. Among authors: kao jt. Nephrology (Carlton). 2024 May;29(5):245-258. doi: 10.1111/nep.14287. Epub 2024 Mar 10. Nephrology (Carlton). 2024. PMID: 38462235 Review.
Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
Cho Y, Sautenet B, Rangan G, Craig JC, Ong ACM, Chapman A, Ahn C, Chen D, Coolican H, Kao JT, Gansevoort R, Perrone R, Harris T, Torres V, Pei Y, Kerr PG, Ryan J, Gutman T, Howell M, Ju A, Manera KE, Teixeira-Pinto A, Hamiwka LA, Tong A. Cho Y, et al. Among authors: kao jt. Trials. 2017 Nov 23;18(1):560. doi: 10.1186/s13063-017-2298-4. Trials. 2017. PMID: 29169385 Free PMC article.
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.
Hsu WF, Lai HC, Chen CK, Wang HW, Chuang PH, Tsai MH, Chen SH, Chu CS, Su WP, Chou JW, Kao JT, Chen HY, Chuang SC, Tsai TY, Hsiao WD, Huang GT, Peng CY. Hsu WF, et al. Among authors: kao jt. Am J Cancer Res. 2023 Feb 15;13(2):654-668. eCollection 2023. Am J Cancer Res. 2023. PMID: 36895987 Free PMC article.
110 results